The Manitowoc Company, Inc.
NYSE:MTWAgricultural - Machinery
+$0.58 today
- Market cap
- $801.94M
- Beta
- 1.75
- P/E (TTM)
- 63.2
- EPS (TTM)
- $0.21
Volume 0.28M
Average 0.23M
MTW Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
The Manitowoc Company, Inc.NYSE: MTW
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization declines year over year
Q1 FY2026 depreciation & amortization of $14.9M fell 4.5% year over year, behind the -1.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 8.6% from the prior quarter. Over 3 fiscal years it compounded at -0.4% a year.
Context
- Depreciation & amortization amounted to 2.8% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -4.5% toward the trailing-twelve-month pace of -1.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 63M USD
- Year-over-year change
- +0.2%
- 4-year CAGR
- +7.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 63M | +0.2% |
| FY2024 | 2024-12-31 | 62.9M | +5.2% |
| FY2023 | 2023-12-31 | 59.8M | -6.1% |
| FY2022 | 2022-12-31 | 63.7M | +35.8% |
| FY2021 | 2021-12-31 | 46.9M | — |
Depreciation & Amortization vs competitors
How MTW compares with its peers on the latest reported figures
- MTW's LTM Mar 2026 depreciation & amortization of $62.3M is the 4th largest of the 10 companies compared; the peer median is $36.5M.
- Its year-over-year change of -1.3% is the 4th highest of 10, against a peer median of -2.1%.
- Depreciation & amortization amounts to 2.8% of revenue for MTW, versus a peer median of 2.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $128.28M | +14.7% | +4.1% | 34.4% | |
| LTM Mar 2026 | $86.13M | -19.4% | -5.9% | 2.7% | |
| LTM Mar 2026 | $71.6M | -2.1% | -2.9% | 4.6% | |
| LTM Mar 2026 | $62.3M | -1.3% | -0.4% | 2.8% | |
| LTM Mar 2026 | $58.73M | -0.9% | +7.7% | 4.0% | |
| LTM Mar 2026 | $36.5M | +12.7% | +2.5% | 6.6% | |
| LTM Mar 2026 | $33M | -1.5% | +3.0% | 2.0% | |
| LTM Mar 2026 | $10.06M | -29.8% | -25.1% | 1.5% | |
| LTM Mar 2026 | $9.1M | -35.5% | -18.1% | 2.4% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $2.7M | -20.9% | -23.2% | 1.6% |
| Peer median (excluding MTW) | $36.5M | -2.1% | -2.9% | 2.7% | |
Competitors are the stored peer set for MTW. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 11M | (123.6M) | 39.2M | 55.8M | 7.2M |
| Depreciation & Amortization | 46.9M | 63.7M | 59.8M | 62.9M | 63M |
| Deferred Income Tax | 600K | (6.6M) | (6M) | (55.6M) | (6.2M) |
| Stock-Based Compensation | 7.1M | 8.5M | 11.5M | 10.9M | 9.5M |
| Change in Working Capital | 3.1M | (35.2M) | (52.1M) | (27.3M) | (52.2M) |
| Accounts Receivables | (4.2M) | (36.4M) | (9.3M) | 9M | (9.1M) |
| Inventory | (68.3M) | (42M) | (46.7M) | 21.4M | (11.6M) |
| Accounts Payables | 62.9M | 40.4M | (28.5M) | (39.1M) | 21.7M |
| Other Working Capital | 12.7M | 2.8M | 32.4M | (18.6M) | (53.2M) |
| Other Non-Cash Items | 7.5M | 170.1M | 10.6M | 2.5M | 900K |
| Operating Cash Flow | 76.2M | 76.9M | 63M | 49.2M | 22.2M |
| Capital Expenditures | (40.4M) | (61.8M) | (77.4M) | (45.7M) | (37.5M) |
| Acquisitions (Net) | (186.2M) | 2.3M | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 300K | 1.5M | 5.6M | 5.3M | (12M) |
| Investing Cash Flow | (226.3M) | (58M) | (71.8M) | (40.4M) | (49.5M) |
| Debt Repayment | 95.1M | (25.1M) | (16.2M) | 27.3M | 60.6M |
| Common Stock Issued | 5.8M | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (3M) | (5.5M) | (5.7M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (1.8M) | 300K | (14.9M) | (5.8M) |
| Financing Cash Flow | 100.9M | (29.9M) | (21.4M) | 6.7M | 54.8M |
| Effect of Forex Changes | (4.1M) | 0 | 200K | (1.9M) | 1.8M |
| Net Change in Cash | (53.3M) | (11M) | (30M) | 13.6M | 29.3M |
| Free Cash Flow | 35.8M | 15.1M | (14.4M) | 3.5M | (15.3M) |
The Manitowoc Company, Inc.
NYSE:MTW
Intrinsic Alpha fair value
Locked
Current Price
$22.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.